| Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity K Patel, A Patil, M Mehta, V Gota, P Vavia International journal of pharmaceutics 472 (1-2), 214-223, 2014 | 69 | 2014 |
| Medium Chain Triglyceride (MCT) Rich, Paclitaxel Loaded Self Nanoemulsifying Preconcentrate (PSNP): A Safe and Efficacious Alternative to Taxol® K Patel, A Patil, M Mehta, V Gota, P Vavia Journal of biomedical nanotechnology 9 (12), 1996-2006, 2013 | 41 | 2013 |
| An update on the animal studies conducted for biosimilar approvals–Regulatory requirement vs actual scenario P Pipalava, R Patel, M Mehta, M Dahiya, I Singh, V Jose Regulatory Toxicology and Pharmacology 107, 104415, 2019 | 16 | 2019 |
| Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT/mTOR pathway M Mehta, D Gohil, N Khattry, R Kumar, S Sandur, D Sharma, R Checker, ... International Immunopharmacology 84, 106575, 2020 | 14 | 2020 |
| Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis SN Patere, PO Pathak, AK Shukla, RK Singh, VK Dubey, MJ Mehta, ... AAPS PharmSciTech 18 (3), 710-720, 2017 | 13 | 2017 |
| Insights into human factor studies conducted for US FDA-approved biological combination products R Patel, M Mehta, P Pipalava, M Dahiya, I Singh, V Jose Expert Opinion on Drug Delivery, 1-21, 2019 | 7 | 2019 |
Ketan PatelProfessor, St John's UniversityVerified email at stjohns.edu
